Company profile
Transdermal Drug Delivery TEPI Patches | Medherant
Medherant is creating a sustainable, next-generation transdermal drug delivery patch company that creates value for patients, partners and investors.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ1NTgzNjg4MWFkaXF6a2N4
Published 20 Feb 2025 03:05
Company registered at Companies House
1 Oct 2018 to 30 Sep 2019
"Medherant seeks to become the world's leading developer of transdermal drug products and has the technology platform, scientific expertise and R&D capabilities to do so. We are developing our own best-in-class products to out-license to global pharma marketing partners alongside offering contract formulation services for companies seeking to develop nove...
